CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Healthleap›
Library
Healthleap

Healthleap

AI inpatient screening that reads hospital patients' full records daily to flag malnutrition risk inside EHR workflows.

Operating headquarters
San Francisco, CA, US🇺🇸
Founded
2022
Loading
Overview
Compare
Fundraising
Employees
News
Library

Healthleap - Library

healthleap.ai·Crawled Oct 10, 2026·

Topics

Publication type

Content origin
Row density

Product

2 pages
  1. Clinical Use & Safety/clinical-use-safety

    Intended use, limitations, safety information, transparency, and regulatory context for Healthleap Nutrition.

  2. Hospital malnutrition screening gap calculator/calculator

    Estimate your hospital's unidentified malnutrition cases and potential financial impact using inpatient discharges and adjustable assumptions.

Blog

2 pages
  1. AI malnutrition screening evidence/evidence

    Read Healthleap's peer-reviewed AI malnutrition screening validation, hospital results, evidence grades, and study limitations.

  2. Penn Medicine AI malnutrition screening results/results/penn-medicine-case-study

    Read Penn Medicine HUP's AI malnutrition screening case study, with hospital-reported financial impact, bed-days saved, and methods.

Press

2 pages
  1. Healthleap Press/press

    Healthleap press releases, company background, media contact information, and coverage from healthcare, technology, and business publications.

  2. Healthleap Raises $38M to Help Hospitals Find Patients with Undiagnosed Conditions/series-a

    Healthleap screens every adult inpatient, every day, at more than 20 hospitals, including Penn Medicine, Houston Methodist, Cedars-Sinai, and Emory Healthcare.

Careers & Hiring

1 page
  1. Join our team/careers

    We're hiring. Help us build AI that empowers clinicians to deliver better care, faster - for every patient, every day.

About

1 page
  1. About Healthleap/about

    Meet Healthleap's co-founders, Josiah and Jemima Meyer, and the clinical team building AI malnutrition screening for hospitals.

Contact

1 page
  1. Contact Healthleap/contact

    Contact Healthleap to learn how validated AI malnutrition screening can help hospital teams identify nutrition risk earlier.

Homepage

2 pages
  1. Homepage/

    Healthleap helps hospital nutrition teams prioritize adult inpatient assessments with daily AI malnutrition screening and nutrition-risk scores in the EHR.

  2. Homepage/

    Healthleap helps hospital nutrition teams prioritize adult inpatient assessments with daily AI malnutrition screening and nutrition-risk scores in the EHR.

Privacy

1 page
  1. Privacy Policy/privacy

    How Healthleap collects, uses, and discloses information from website visitors.

Terms & Conditions

1 page
  1. Terms of Service/terms

    Terms governing use of the Healthleap website.

Coverage

5 items
  1. Healthleap Raises $38 Million to Expand AI-Powered Inpatient Screening Platformhlth.com/insights/news/healthleap-raises-38-million-to-expand-ai-powered-inpatient-screening-platform

    Healthleap, a clinical AI company developing automated inpatient screening technology, raises $38 million in combined seed and Series A financing to expand its platform.

    Oct 2026 · HLTHNews article

  2. Healthleap raises $38M for its AI that flags hospital patients who may need a closer looktechcrunch.com/2026/10/07/healthleap-raises-38m-for-its-ai-that-flags-hospital-patients-who-may-need-a-closer-look/

    Healthleap raises $38 million in seed and Series A funding for an AI platform that flags hospital patients who may have undiagnosed conditions. Deployed in more than 50 hospitals, the software combines clinical notes with structured record data to flag patients for review, including for malnutrition and delirium. The financing includes an $8 million seed co-led by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures.

    Oct 2026 · TechCrunchNews article

  3. Healthleap Raises $38M for Clinical AI Screening Platform Targeting Overlooked Inpatient Conditionshitconsultant.net/2026/10/07/healthleap-raises-38m-series-a-sequoia-first-round-clinical-ai-inpatient-screening/

    Healthleap raises $38 million from Sequoia, First Round, and Hummingbird to scale its clinical AI platform. The platform scans full electronic health records to flag undiagnosed conditions in inpatients.

    Oct 2026 · hitconsultant.netNews article

  4. HealthLeap Appoints New Executive Leadership to Accelerate Growth in 2026prnewswire.com/news-releases/healthleap-appoints-new-executive-leadership-to-accelerate-growth-in-2026-302658604.html

    HealthLeap announces new executive leadership to accelerate growth in 2026. The company describes its AI platform as helping clinicians prioritize and care for patients.

    Jan 2026 · PR NewswireNews article